# Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

> **NCT00665951** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 12 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00665951
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665951, "Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00665951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*